Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Deayea Technology appears to be a Shanghai-based neurotechnology company focused on brain-monitoring hardware and software rather than a drug-development biotech company. Public reporting links the company to wearable EEG-based systems used for worker and driver cognitive-state monitoring, including deployment in rail applications. Available evidence suggests the business is oriented toward biosignal acquisition, signal processing, pattern recognition, and AI-enabled analysis of human neurophysiological data. It therefore fits better as a medical-device or digital-health company than as a therapeutics developer, and no clear pharmaceutical pipeline, drug assets, or clinical-stage therapeutics programs were identified.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Deayea Technology.